Concepedia

Gustavo E. Velásquez

GE

Statistics

Publications

19

Citations

592

H-Index

14

Active since

1988

Affiliations

Brigham and Women's Hospital(Current)

Harvard Global Health Institute

Harvard University

Partners In Health

EsSALUD

Gustavo E. Velásquez is an author at Brigham and Women's Hospital specializing in tuberculosis control, pharmacology, and clinical pharmacology.

ORCID

Publications per year

1988–2025

19

Publications

19

Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial

Gustavo E. Velásquez, Meredith B. Brooks, Julia Coit et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 113 citations

, , +13

Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis

Lorenzo Guglielmetti, Uzma Khan, Gustavo E. Velásquez et al. · New England Journal of Medicine · 2025 · 76 citations · Full text

, , +16

Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death

Gustavo E. Velásquez, M. C. Becerra, Irina Gelmanova et al. · Clinical Infectious Diseases · 2014 · 51 citations · Full text

, , +15

Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series

Jeffrey C Pearson, Brandon Dionne, Aaron Richterman et al. · Open Forum Infectious Diseases · 2020 · 50 citations · Full text

, , +17

Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis

Charles A. Peloquin, Gustavo E. Velásquez, Leonid Lecca et al. · Antimicrobial Agents and Chemotherapy · 2017 · 43 citations · Full text

, , +11

1–5 of 19